Ophthalmic compositions containing a synergistic combination of three polymers
Ophthalmic compositions suitable for use as artificial tears or as vehicles for ophthalmic drugs are disclosed. The compositions contain a combination of three polymers that have a synergistic effect on viscosity.
1. A method of treating a disease or condition of the eye comprising administering to the eye a composition comprising an ophthalmic drug and a carrier wherein the carrier comprises three polymeric ingredients having a synergistic effect on the composition's viscosity and wherein the three polymeric ingredients are a) guar gum, b) hydroxypropyl methyl cellulose and c) carboxyvinyl polymer, provided that if the composition comprises a carboxyvinyl polymer then the composition does not contain sodium chloride or boric acid wherein the viscosity of the composition is greater than 150% of the sum of the viscosities of three single polymer compositions that contain only one of the three polymer ingredients, respectively.
2. The method of claim 1 wherein the composition is administered topically to the eye.
3. The method of claim 1 wherein the composition is injected.
4. The method of claim 3 wherein the composition is injected as an intravitreal injection, subconjunctival injection, sub-tenon injection, retrobulbar injection, suprachoroidal injection, or periocular injection.
5. The method of claim 1 wherein the guar gum ingredient is hydroxypropyl guar.
6. The method of claim 1 wherein the composition includes the carboxyvinyl polymer and the carboxyvinyl polymer is a polymer of acrylic acid crosslinked with allyl sucrose or allylpentaerythritol.
7. The method of claim 1 wherein the three polymeric ingredients are present in a ratio of 1:1:1 to 3:3:3, and the total concentration of the three polymeric ingredients ranges from 0.1-1% (w/v).
8. The method of claim 1 wherein the total concentration of the three polymeric ingredients ranges from 0.4-0.7% (w/v).
9. The method of claim 1 wherein the ophthalmic drug is selected from the group consisting of anti-glaucoma agents; anti-angiogenesis agents; anti-infective agents; non-steroidal and steroidal anti-inflammatory agents; growth factors; immunosuppressant agents; and anti-allergic agents.
10. The method of claim 1 wherein the composition has a pH of 6-8 and an osmolality in the range of 235-300 mOsm/kg.
11. A method of treating a disease or condition of the eye comprising administering to the eye a composition comprising an ophthalmic drug and a carrier wherein the carrier comprises three polymeric ingredients having a synergistic effect on the composition's viscosity and wherein the three polymeric ingredients are a) guar gum, b) hydroxypropyl methyl cellulose and c) carboxyvinyl polymer; or wherein the three polymeric ingredients are hydroxypropyl methylcellulose and a combination of two polymers selected from the group of combinations consisting of guar gum and a carboxyvinyl polymer; guar gum and hydroxyethyl cellulose; guar gum and dextran; hydroxyethyl cellulose and a carboxyvinyl polymer; and dextran and a carboxyvinyl polymer wherein the viscosity of the composition is greater than 150% of the sum of the viscosities of three single polymer compositions that contain only one of the three polymer ingredients, respectively.
12. The method of claim 11 wherein the composition is administered topically to the eye.
13. The method of claim 11 wherein the composition is injected.
14. The method of claim 13 wherein the composition is injected as an intravitreal injection, subconjunctival injection, sub-tenon injection, retrobulbar injection, suprachoroidal injection, or periocular injection.
15. The method of claim 11 wherein the guar gum ingredient is hydroxypropyl guar.
16. The method of claim 11 wherein the carboxyvinyl polymer is a polymer of acrylic acid crosslinked with allyl sucrose or allylpentaerythritol.
17. The method of claim 11 wherein the three polymeric ingredients are present in a ratio of 1:1:1 to 3:3:3, and the total concentration of the three polymeric ingredients ranges from 0.1-1% (w/v).
18. The method of claim 11 wherein the total concentration of the three polymeric ingredients ranges from 0.4-0.7% (w/v).
19. The method of claim 11 wherein the ophthalmic drug is selected from the group consisting of anti-glaucoma agents; anti-angiogenesis agents; anti-infective agents; non-steroidal and steroidal anti-inflammatory agents; growth factors; immunosuppressant agents; and anti-allergic agents.
20. The method of claim 11 wherein the composition has a pH of 6-8 and an osmolality in the range of 235-300 mOsm/kg.